Waldencast plc (NASDAQ:WALD – Get Free Report) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 710,500 shares, a growth of 20.4% from the September 30th total of 590,300 shares. Based on an average daily volume of 210,500 shares, the days-to-cover ratio is currently 3.4 days. Approximately 3.1% of the company’s stock are short sold.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the company. Telsey Advisory Group reaffirmed an “outperform” rating and set a $6.00 price objective on shares of Waldencast in a research report on Wednesday, October 9th. Canaccord Genuity Group started coverage on Waldencast in a research report on Friday. They set a “buy” rating and a $5.00 price target for the company. Canaccord Genuity Group initiated coverage on shares of Waldencast in a report on Friday. They issued a “buy” rating and a $5.00 price objective on the stock. Finally, DA Davidson increased their target price on shares of Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a report on Wednesday, September 4th.
Get Our Latest Analysis on Waldencast
Hedge Funds Weigh In On Waldencast
Waldencast Stock Performance
NASDAQ WALD traded up $0.27 during trading hours on Monday, hitting $3.76. 20,491 shares of the company traded hands, compared to its average volume of 135,721. Waldencast has a twelve month low of $2.40 and a twelve month high of $12.00. The business’s 50-day moving average is $3.54 and its 200-day moving average is $3.89. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Stories
- Five stocks we like better than Waldencast
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Oil Stocks to Watch Before Earnings Come Out
- Which Wall Street Analysts are the Most Accurate?
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
- What is a Dividend King?
- Alphabet’s Earnings Could Surprise—Should You Buy Now?
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.